Search Close Search
Search Close Search
Page Menu


The PHARE Study group seeks to: 


1)    Describe burden of illness and understand factors that drive
       the use of medications and health care services in vulnerable

2)    Conduct rigorous pharmacoepidemiologic research to
       advance understanding of beneficial and adverse effects
       of medications in populations systematically excluded from
       clinical trials;

 3)    Develop novel approaches leveraging large administrative data sources to understand the heterogeneity of
        treatment effects in clinically complex patients;

 4)    Evaluate the extent to which advanced statistical methods reduce the impact of selection bias, confounding,
        misclassification and missing data;

 5)    Translate and disseminate research findings to inform health care policy and practice, and

 6)    Educate, train, and mentor current and future scientists.